Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada

This survey analyzes two national pharmacovigilance databases in order to determine the major adverse reactions observed with the use of cholinesterase inhibitors in dementia. We conducted a statistical analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) and the Canad...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Thibault B., Schleret, Thomas R., Reilly, Brian M., Chen, Winston Yuchen, Abagyan, Ruben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671709/
https://www.ncbi.nlm.nih.gov/pubmed/26642212
http://dx.doi.org/10.1371/journal.pone.0144337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671709/
https://www.ncbi.nlm.nih.gov/pubmed/26642212
http://dx.doi.org/10.1371/journal.pone.0144337

Ejemplares similares